Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Restorix Research Institute (RRI) is the clinical research division of RestorixHealth, a leading provider of wound care management and amputation prevention services. The institute is dedicated to advancing the science of hyperbaric oxygen therapy (HBOT) and developing evidence-based protocols for chronic and acute wound healing, as well as neurological conditions such as traumatic brain injury (TBI) and stroke. RRI collaborates with academic institutions, healthcare systems, and industry partners to conduct clinical trials that evaluate the efficacy of HBOT in accelerating recovery and improving patient outcomes. Through its affiliation with RestorixHealth, RRI integrates research findings into clinical practice across a national network of nearly 300 wound healing centers. The institute's work is pivotal in establishing new standards of care for underserved patient populations with complex medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Restorix Research Institute.